Cite
Glucagon‐like peptide‐1 receptor agonists as adjunctive treatment for type 1 diabetes: Renewed opportunities through tailored approaches?
MLA
Kobayati, Alessandra, et al. “Glucagon‐like Peptide‐1 Receptor Agonists as Adjunctive Treatment for Type 1 Diabetes: Renewed Opportunities through Tailored Approaches?” Diabetes, Obesity & Metabolism, vol. 24, no. 5, May 2022, pp. 769–87. EBSCOhost, https://doi.org/10.1111/dom.14637.
APA
Kobayati, A., Haidar, A., & Tsoukas, M. A. (2022). Glucagon‐like peptide‐1 receptor agonists as adjunctive treatment for type 1 diabetes: Renewed opportunities through tailored approaches? Diabetes, Obesity & Metabolism, 24(5), 769–787. https://doi.org/10.1111/dom.14637
Chicago
Kobayati, Alessandra, Ahmad Haidar, and Michael A. Tsoukas. 2022. “Glucagon‐like Peptide‐1 Receptor Agonists as Adjunctive Treatment for Type 1 Diabetes: Renewed Opportunities through Tailored Approaches?” Diabetes, Obesity & Metabolism 24 (5): 769–87. doi:10.1111/dom.14637.